Publication | Open Access

Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis

NanoparticlesNanomedicineInflammationDrug TargetingNanotherapeuticsEngineeringImmunologyPharmaceutical NanotechnologyDrug Delivery SystemsNano-drug DeliveryInnate ImmunityBiomedical EngineeringColonic MacrophagesExperimental ColitisMedicineEffective Therapy